Cipla

Cipla Goodwill

The Goodwill of Cipla (CIPLA.NS) as of Oct 17, 2026 is 37.54 B INR. In the previous year, Goodwill was 32.70 B INR — a change of 14.80% (higher).

Goodwill

37.54 BINR

YoY

14.80%

Last updated:

Goodwill of Cipla is 2026 37.54 B INR. Goodwill of Cipla was 2025 32.70 B INR. It decreases by 14.80% higher compared to the previous year.

The Cipla Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2019
28.69 B INR
Jan 1, 2020
29.34 B INR
Jan 1, 2021
30.07 B INR
Jan 1, 2022
31.38 B INR
Jan 1, 2023
29.84 B INR
Jan 1, 2024
31.12 B INR
Jan 1, 2025
32.70 B INR
Jan 1, 2026
37.54 B INR
The Cipla Goodwill history
YEARGoodwillYoY
37.54 BINR+14.80%
32.70 BINR+5.08%
31.12 BINR+4.30%
29.84 BINR-4.91%
31.38 BINR+4.34%
30.07 BINR+2.50%
29.34 BINR+2.26%
28.69 BINR+1.93%
28.15 BINR+4.38%
26.97 BINR-0.33%
27.06 BINR+5.35%
25.68 BINR+3.01%
24.93 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cipla Stock analysis

What does Cipla do? Cipla Ltd is an Indian pharmaceutical company based in Mumbai. The company was founded in 1935 and is now one of the largest producers of generics worldwide. The name "Cipla" is an abbreviation for "Chemical, Industrial & Pharmaceutical Laboratories". Business Model: Cipla specializes in the production of high-quality generics. This means that they manufacture medication that has the same active ingredients as the original drugs. This allows them to offer medication at a significantly lower price. However, Cipla not only offers generics but also develops its own innovative medication. The focus is on therapy areas such as oncology, respiratory diseases, HIV/AIDS, diabetes, and cardiovascular diseases. Divisions: Cipla is divided into several divisions, including generics, specialty drugs, and biologics. The generics division is the company's core competence. Here, Cipla produces a variety of medications in different forms, such as tablets, capsules, suspensions, etc. The specialty drugs division focuses on innovative medications that are usually more expensive than generics. This includes medications for the treatment of cancer or autoimmune diseases. In the biologics division, Cipla produces biotechnology products based on the use of living cells. Products: Cipla offers a wide range of products, including medications for asthma, diabetes, hypertension, and infectious diseases. Some of the most well-known medications are Escitalopram (an antidepressant), Seroflo (an asthma medication), Tenofovir (an HIV medication), and Sorafenib (a cancer medication). The company continuously works on new products and invests heavily in research and development. Cipla also has a social responsibility. The company is involved in the fight against HIV/AIDS and produces life-saving medication for this disease at an affordable price. Furthermore, Cipla has launched a program called "Cipla Foundation" which works towards improving healthcare in developing countries. Overall, Cipla has achieved impressive growth and is now one of the most significant pharmaceutical companies worldwide. The company has proven that it is possible to offer high-quality medication at an affordable price and still be successful. Cipla is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cipla stock

Goodwill of Cipla is 37.54 B INR in 2026.

Goodwill of Cipla changed from 32.70 B INR to 37.54 B INR, representing a 14.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Cipla since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Cipla historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cipla

All Key Metrics — Cipla